To understand what this amazing new drug is we must go back to 2017 when the FDA first approved it for adults with Type 2 diabetes, you remember the jingle (Oh Oh Oh Ozempic)!
That’s right, an injectable medication that helped diabetics is now being sought after by body builders, soccer moms, fitness fanatics & everyday people wanting to lose weight.
We’re not talking a few pounds ( here & there) kind of weight loss, we’re talking 15% of Total Body Weight kind of weight loss!
Semaglutide, a medicine that mimics a natural hormone called glucagon-like peptide 1 (GLP)-1 is produced in our body after eating.
Drugs belonging the GLP1 drug class are normally given as injections,
(benefits & downfall of Botox) and some already exist on market treating diseases such type 2 diabetes or obesity; however recent studies show Semaglutide has beneficial effects against your cardiovascular system including reducing blood pressure levels while improving fat concentrations within your bloodstream.
Ozempic V.S Wegovy
Ozempic and Wegovy are two brand names that Novo Nordisk uses to market their injectable Semaglutide.
Ozempic is used for type 2 diabetes, with a secondary benefit of weight loss, while Wegovy was formulated specifically for weight loss (see sleep). What do these FDA approved weight loss medications have in common…Semaglutide.
Ozempic for weight loss
Ozempic is a prescription medication that can help to control your blood sugar, but people taking them also tend lose weight.
What makes this drug so special is this key hormone dictates how fast your stomach empties itself of food AKA (Gastric Emptying).
While on this new weight loss drug your Pancreas releases more insulin, while blocking a hormone that releases sugar via your liver.
Wegovy For Weight Loss (see essential oils for weight loss)
Wegovy can help you lose weight by mimicking a hormone that targets areas in the brain involving regulating appetite and food intake.
This means it’s possible for people who take this supplement will be able eat less which leads them having significant weight loss.
While the two medications have many similarities, they also differ in some key ways.
For example, Wegovy® is specifically indicated for overweight and obesity while Ozempic ® has been shown to be a combination therapy that’s an effective treatment option against type 2 diabetes as well as weight loss.
Other Sources of Semaglutide
Semaglutide is not available OTC, so those who want to take it must receive a prescription from their doctor.
Out of curiosity we searched online for alternative providers of this wonder drug & in no time at all we found a few options (We do not recommend you purchase any of these “alternative” products) Caveat Emptor!
Diet Pills That Really Work
The number of American adults living with obesity or are overweight is growing.
This has serious health consequences including an increased risk for heart disease, stroke and diabetes (lose weight safely while diabetic) which are linked to death from certain cancers as well!
If you’re one those 70% who carries extra pounds around on their body – it might be time get committed towards losing 5%-10%. A diet alone can reduce your chances by up to 30% just imagine what the combined health effects could be if you obtained one of these potentially lifesaving weight loss treatments.
Conclusion:
It is no wonder that Novo Nordisk’s Semaglutide has been called the “Holy Grail of Weight Loss.””
The FDA-approved medication not only helps to control blood sugar, but it also seems to help people lose weight.
If you are struggling with your weight, talk to your doctor about whether Ozempic or Wegovy might be right for you. Both medications have shown great promise in helping people achieve their desired weight loss (see also ‘Weight Loss Tips on a Vegan Diet‘) goals.
- Why is My Poop Black: Uncovering the Causes and Solutions - December 21, 2023
- Clear Protein Drinks: Optimal Hydration and Muscle Support for Athletes and Fitness Enthusiasts - December 21, 2023
- Does Apple Juice Make You Poop: Uncovering the Digestive Effects - November 29, 2023
